Indicated for: bacterial infections
Route of administration: injectable / infusion
Substance: ticarcillin + clavulanic acid (penicillin antibiotic + beta-lactam antibiotic)
ATC: J01CR03 (Antiinfectives for systemic use | Beta-lactam antibacterials, penicillins | Combinations of penicillins, incl. beta-lactamase inhibitors)
This combination of ticarcillin and clavulanic acid is an antibiotic used for the treatment of severe bacterial infections, including respiratory, urinary, intra-abdominal, and skin infections. Ticarcillin is a penicillin-class antibiotic, and clavulanic acid inhibits beta-lactamases produced by bacteria, enhancing ticarcillin's effectiveness.
The medication is administered intravenously, as directed by a doctor, and the dosage is adjusted based on the severity of the infection and the patient's condition. It is important for patients to complete the prescribed course of treatment.
Patients should be monitored for potential side effects, such as allergic reactions, diarrhea, or elevated liver enzymes. It is important to inform the doctor of any unusual symptoms.
Common side effects include diarrhea, nausea, skin rashes, and injection site reactions. In rare cases, severe reactions such as pseudomembranous colitis or anaphylactic reactions may occur. Patients should be informed of these risks before starting treatment.